Illumina Inc (ILMN)
122.87
-1.59
(-1.28%)
USD |
NASDAQ |
Apr 24, 16:00
123.68
+0.81
(+0.66%)
After-Hours: 05:30
Illumina Enterprise Value: 19.96B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 19.96B |
April 23, 2024 | 20.21B |
April 22, 2024 | 19.54B |
April 19, 2024 | 19.09B |
April 18, 2024 | 18.98B |
April 17, 2024 | 19.23B |
April 16, 2024 | 19.14B |
April 15, 2024 | 19.69B |
April 12, 2024 | 20.63B |
April 11, 2024 | 21.20B |
April 10, 2024 | 21.28B |
April 09, 2024 | 21.66B |
April 08, 2024 | 21.11B |
April 05, 2024 | 20.73B |
April 04, 2024 | 20.46B |
April 03, 2024 | 20.73B |
April 02, 2024 | 20.86B |
April 01, 2024 | 21.52B |
March 28, 2024 | 22.26B |
March 27, 2024 | 22.47B |
March 26, 2024 | 21.70B |
March 25, 2024 | 21.74B |
March 22, 2024 | 22.24B |
March 21, 2024 | 22.28B |
March 20, 2024 | 21.60B |
Date | Value |
---|---|
March 19, 2024 | 21.59B |
March 18, 2024 | 21.11B |
March 15, 2024 | 20.73B |
March 14, 2024 | 20.79B |
March 13, 2024 | 21.53B |
March 12, 2024 | 21.52B |
March 11, 2024 | 22.53B |
March 08, 2024 | 21.95B |
March 07, 2024 | 22.05B |
March 06, 2024 | 21.91B |
March 05, 2024 | 21.84B |
March 04, 2024 | 22.32B |
March 01, 2024 | 22.76B |
February 29, 2024 | 22.65B |
February 28, 2024 | 22.84B |
February 27, 2024 | 22.64B |
February 26, 2024 | 22.20B |
February 23, 2024 | 21.57B |
February 22, 2024 | 21.97B |
February 21, 2024 | 22.11B |
February 20, 2024 | 22.69B |
February 16, 2024 | 23.22B |
February 15, 2024 | 23.65B |
February 14, 2024 | 22.80B |
February 13, 2024 | 21.69B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
15.29B
Minimum
Nov 13 2023
77.30B
Maximum
Aug 18 2021
42.70B
Average
42.30B
Median
Feb 19 2020
Enterprise Value Benchmarks
Exact Sciences Corp | 13.07B |
Guardant Health Inc | 2.174B |
Mettler-Toledo International Inc | 28.55B |
Natera Inc | 10.53B |
Castle Biosciences Inc | 304.78M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -175.00M |
Revenue (Quarterly) | 1.122B |
Total Expenses (Quarterly) | 1.274B |
EPS Diluted (Quarterly) | -1.11 |
Gross Profit Margin (Quarterly) | 60.07% |
Profit Margin (Quarterly) | -15.60% |
Earnings Yield | -5.97% |
Normalized Earnings Yield | -1.682 |